Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia

Fig. 2

Comorbid conditions at enrollment (all patients with schizophrenia). Medical (a) and behavioral (b) comorbid conditions. APT, antipsychotic therapy; LAI, long-acting injectable (includes paliperidone palmitate long-acting injectable and risperidone long-acting injectable). Values in bars are n/N. *P < 0.05 vs oral APT

Back to article page